Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

143 clinical studies listed.

Filters:

Urinary Incontinence

Tundra lists 143 Urinary Incontinence clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.

This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.

COMPLETED

NCT06620419

Clinical Study of External Electrical Stimulation for Male Incontinence

The purpose of this research is to evaluate the effectiveness of the Elidah neuromuscular stimulation treatment to reduce incontinence in men post-prostatectomy.

Gender: MALE

Ages: 18 Years - 80 Years

Updated: 2026-11-19

1 state

Urinary Incontinence
RECRUITING

NCT07948330

rTMS for Incontinence After Prostate Treatment

Incontinence after prostate treatment (IPT) affects up to 25% of men following radical prostatectomy or other prostate therapies, primarily resulting from sphincteric weakness and impaired neuromuscular control. Current management options, including behavioral therapy and surgical implants, are often limited by modest effectiveness or invasiveness. Emerging neuroimaging evidence demonstrates that the pelvic supplementary motor area (pSMA) in the brain plays a critical regulatory role in controlling pelvic floor muscles and urethral sphincter activity. This proof-of-concept, prospective, randomized clinical trial aims to evaluate the safety, tolerability, acceptability, and procedural feasibility of targeting the pSMA using non-invasive repetitive transcranial magnetic stimulation (rTMS) in adult males with IPT, alongside a cohort of continent controls. A total of 23 participants will be enrolled (targeting 10 evaluable IPT subjects and 10 continent controls). Participants undergo baseline fMRI using a natural bladder filling protocol, and a randomized, single-session neuronavigated rTMS protocol with concurrent pelvic floor electromyography (EMG) and functional Magnetic Resonance Imaging (fMRI) to evaluate physiological and neurofunctional changes. Safety and adverse events are monitored closely through a 1-month virtual follow-up visit. Findings from this study will establish foundational evidence for cortical modulation of pelvic floor control in IPT. Additionally, these results will guide the design of a future larger, clinical trial to optimize rTMS parameters and integrate brain neuromodulation into post-prostate treatment rehabilitation strategies.

Gender: MALE

Ages: 22 Years - 80 Years

Updated: 2026-11-19

1 state

Urinary Incontinence
Prostate Treatment
Incontinence After Prostate Treatment
COMPLETED

NCT06481436

Use of Artificial Intelligence by Urogynecologic Patients

The goal of this clinical trial is to learn about how Urogynecology patients use Artificial Intelligence (AI) Chatbots like ChatGPT, and how it affects healthcare decision making. The main question\[s\] it aims to answer are: * How does the AI Chatbot affect participants' understanding of diagnoses and participant satisfaction with a urogynecology consultation? * How accurate is the chatbot-provided diagnosis and counseling information? Participants will be asked to use the ChatGPT chatbot and ask it questions about the main problem the participant is seeing the doctor for, and will also be asked to fill out some questionnaires. Researchers will compare using the Chatbot before the visit, after the visit, or not at all to see if the way participants understand the information changes based on timing of use.

Gender: FEMALE

Ages: 18 Years - 89 Years

Updated: 2026-11-16

1 state

Uterovaginal Prolapse
Urinary Incontinence
Lower Urinary Tract Symptoms
NOT YET RECRUITING

NCT07798128

Evaluation of Catheter Utilization in Female Patients Using Indwelling Urinary Catheters and the PureWick™ Flex Female External Catheter

Urinary catheterization is commonly used in hospitalized patients for the management of urinary incontinence, immobilization, and monitoring of urinary output. However, indwelling urinary catheters (IUCs) are associated with clinically significant risks, including catheter-associated urinary tract infections (CAUTIs), other infectious and non-infectious complications, prolonged hospital stay, and increased healthcare costs. The risk of complications increases with the duration of catheterization, highlighting the need for strategies to reduce unnecessary catheter use and minimize catheter dwell time. The PureWick™ Female External Catheter (FFEC) is a non-invasive urine collection device designed to manage urinary incontinence in female patients without the need for an indwelling catheter. By providing an alternative approach to urinary management, it has the potential to reduce reliance on IUCs and associated complications while improving patient comfort and quality of care. This study is a prospective, multinational, observational, sequential two-cohort study conducted in hospitalized adult female patients across Europe and the Middle East. The study aims to evaluate the effect of introducing the PureWick™ FFEC into clinical practice on indwelling urinary catheter utilization rates in routine hospital care. Approximately 240 adult female patients requiring urinary management for incontinence during hospitalization will be enrolled across multiple clinical sites. The study consists of two sequential cohorts within participating sites. In Cohort 1, patients will receive standard care using indwelling urinary catheters only. In Cohort 2, following the introduction of the PureWick™ FFEC, patients will be managed using either the external catheter alone or in combination with indwelling catheters, according to routine clinical practice. The primary objective is to compare indwelling urinary catheter utilization rates before and after the introduction of the PureWick™ FFEC. Catheter utilization is defined as the proportion of inpatient days during which an indwelling catheter is used (catheter-days per patient-days). Secondary objectives include assessment of the occurrence and nature of adverse events, including urinary tract infections, catheter-associated urinary tract infections, incontinence-associated dermatitis, and falls, as well as evaluation of hospital length of stay. Exploratory objectives include assessment of patient and healthcare professional experience, device usability and satisfaction, pain and discomfort, and sleep quality. Participants will be followed from enrollment until hospital discharge or up to 40 days, whichever occurs first. The results of this study are intended to provide real-world evidence on urinary catheter utilization patterns and to inform clinical practice regarding the role of non-invasive urinary management strategies in hospitalized female patients.

Gender: FEMALE

Ages: 18 Years - Any

Updated: 2026-11-13

Urinary Incontinence
Limited Mobility
COMPLETED

NCT06231394

Effectiveness of Multimodal Pelvic Floor Rehabilitation Program in Children With Different Types of Urinary Incontinence

Urinary incontinence is defined by the International Children's Continence Society as involuntary urinary leakage that can be continuous or intermittent in children aged five and over. Urinary incontinence is divided into subgroups of daytime incontinence, nocturnal enuresis and combined daytime incontinence and nocturnal enuresis. Different pelvic floor rehabilitation programs appear to be effective in children with daytime incontinence and nocturnal enuresis but mostly focus on the pelvic floor muscle training component. However, pelvic floor rehabilitation includes many components such as education, lifestyle changes, manual techniques, pelvic floor muscle training, functional exercises, biofeedback therapy, electrical stimulation and home program. However, there is no study examining the effectiveness of a multimodal pelvic floor rehabilitation program in the treatment of children with urinary incontinence. It is also unclear for which urinary incontinence type the multimodal pelvic floor rehabilitation program will be more effective. Therefore, investigators aim to compare the effects of a multimodal pelvic floor rehabilitation program on lower urinary tract symptoms, pelvic floor muscles and other related muscle functions in children with different urinary incontinence types. Children between the ages of 5 and 18 who were diagnosed with urinary incontinence by applying to Ege University Faculty of Medicine, Department of Pediatric Urology will be included in the study. Participants will be divided into three groups: daytime incontinence, nocturnal enuresis, and combined daytime incontinence and nocturnal enuresis. A multimodal pelvic floor rehabilitation program will be performed on all children for 10 weeks, two days a week and approximately 45 minutes. A multimodal pelvic floor rehabilitation program will include education, bladder and bowel training, manual techniques, exercise training (diaphragmatic breathing exercise, pelvic floor muscle training, trunk stabilization exercises based on developmental kinesiology) and a home program. Children's lower urinary symptoms will be assessed with the Dysfunctional Voiding and Incontinence Scoring System, Bladder and Bowel Dysfunction Questionnaire, Childhood Bladder and Bowel Dysfunction Questionnaire, bladder and bowel diary, and the functions of the pelvic floor muscles and other related muscles will be assessed with superficial electromyography and ultrasonography.

Gender: All

Ages: 5 Years - 18 Years

Updated: 2026-11-12

1 state

Urinary Incontinence
Nocturnal Enuresis
Daytime Wetting
+3
NOT YET RECRUITING

NCT07931924

Functional Outcomes of the Miami Pouch Continent Cutaneous Urinary Diversion: A Quality of Life Study

The Miami Pouch is a continent cutaneous urinary diversion using the plicated right colon and the ileocecal valve as a catheterizable continent stoma. Despite its long history, functional outcomes remain poorly reported, with no consensus on continence definition or standardized assessment tools. This single-center cross sectional cohort study evaluates functional outcomes in patients who underwent Miami Pouch urinary diversion at Hôpital Lyon Sud (Hospices Civils de Lyon, France) between 2015 and 2025. Patients were identified through institutional medical coding (PMSI) and contacted by telephone to complete validated patient-reported outcome measures. The primary objective is to assess stomal continence using the International Consultation on Incontinence Questionnaire - Short Form (ICIQ-SF). Hypothesis: The Miami Pouch provides acceptable long-term stomal continence with limited impact on digestive function.

Gender: All

Ages: 18 Years - Any

Updated: 2026-11-12

Urinary Diversion
Urinary Bladder Carcinoma
Neurogenic Bladder
+2
COMPLETED

NCT07108062

Using Tele-rehabilitation on Management of Pediatric Nocturnal Enuresis

Objective: To evaluate the effectiveness of telerehabilitation (via lifestyle and dietary advice) in managing primary nocturnal enuresis (bedwetting) in children aged 5-10 years. Background: Nocturnal enuresis is common in children and can be influenced by genetic, hormonal, and bladder-related factors. Treatment includes behavioral, pharmacological, and psychological approaches. Telerehabilitation-remote delivery of care-emerged during the COVID-19 pandemic as a promising tool for maintaining continuity of care. Methodology: Design: Randomized Controlled Trial Participants: Children aged 5-10 with primary NE (wetting ≥4 nights/week), recruited online. Exclusion: Children with secondary NE due to medical conditions or those on medication. Groups: Study group: Received telerehabilitation (lifestyle + dietary guidance). Control group: No telerehabilitation. Duration: 3 weeks (1 week baseline, 1 week intervention, 1 week follow-up) Assessment: Number of wet nights per week (using ICCS classification: responders, partial responders, non-responders) Pediatric quality of life Intervention Details: Telerehabilitation involved dietary recommendations (e.g., reducing evening fluid intake, avoiding caffeine/chocolate), lifestyle tips, and motivational counseling delivered remotely to caregivers. Data Analysis: Pre- and post-intervention outcomes compared using paired t-tests. Demographics and clinical characteristics recorded.

Gender: All

Ages: 5 Years - 10 Years

Updated: 2026-11-12

1 state

Enuresis Nocturnal
Urinary Incontinence
COMPLETED

NCT02995421

Transcutaneous Electrical Stimulation for Stress Urinary Incontinence

This study evaluates surface electrical muscle stimulation for women with incontinence symptoms. Phase I is a single-session study to test usability, comfort and tolerability at various waveforms. Phase II is a six-week at-home study to test compliance and efficacy.

Gender: FEMALE

Ages: 18 Years - 80 Years

Updated: 2026-11-09

1 state

Stress Urinary Incontinence
Urinary Incontinence
ACTIVE NOT RECRUITING

NCT05878951

Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms

The objective of our multi-center randomized single-blind study is to examine the safety and effect of intra-detrusor OnabotulinumtoxinA injections at the time of holium laser enucleation of the prostate (HoLEP) in men with overactive bladder symptoms with and without urge incontinence.

Gender: MALE

Ages: 18 Years - 89 Years

Updated: 2026-11-06

1 state

Urinary Incontinence
Overactive Bladder Syndrome
Overactive Bladder
+1
RECRUITING

NCT05874375

UCon Treatment of Overactive Bladder (OAB) in Males

UCon is a medical device for treatment of the symptoms of OAB and fecal incontinence (FI). It electrically stimulates the DGN through the skin to obtain modulated behaviour of the bladder musculature e.g., suppress undesired bladder activity to relieve the symptoms of the patient. This clinical investigation is a randomized, cross-over, single-site, prospective, early feasibility study, which is used to evaluate Ucon with respect to its initial clinical safety and device performance in a small number of males with OAB.

Gender: MALE

Ages: 18 Years - Any

Updated: 2026-11-06

Urinary Incontinence
Urge Incontinence
Nocturia
+3
RECRUITING

NCT06754189

Safety and Performance of UCon Patch Electrode

UCon is a medical device for treating the symptoms of overactive bladder (OAB) and bowel dysfunction (BD). It electrically stimulates the DGN through the skin to obtain modulated behavior of the bladder/bowel musculature e.g., suppressing undesired bladder/bowel activity to relieve the symptoms of the patient. This pivotal clinical investigation is designed as a stratified-randomized, single-blinded, controlled, confirmatory, prospective, multicenter clinical investigation.

Gender: All

Ages: 18 Years - Any

Updated: 2026-11-06

Urinary Incontinence
Urinary Incontinence, Urge
Nocturia
+5
RECRUITING

NCT07685249

Rehabilitation and Sex Therapy to Optimize Recovery After Prostate Cancer Treatment

This study is being done at Duke Health and includes adult men who have been treated for localized prostate cancer. The goal is to see if it is feasible and acceptable to offer sex therapy by telehealth after prostate cancer treatment. All participants receive pelvic floor physical therapy and education about penile rehabilitation, including use of a vacuum erection device. Participants are randomly assigned to one of two groups. One group receives pelvic floor physical therapy plus telehealth sex therapy, with about ten sessions over six months. The other group receives pelvic floor physical therapy alone. Participants complete questionnaires about urinary and sexual health at the start of the study and over the next two years. Short interviews are also done at 6 and 12 months. Medicines for erectile function are prescribed as part of usual clinical care and are not part of the study treatment.

Gender: MALE

Ages: 18 Years - Any

Updated: 2026-11-06

1 state

Prostate Cancer
Urinary Incontinence
Erectile Dysfunction
NOT YET RECRUITING

NCT07906431

Radiofrequency and Pelvic Floor-Core Exercise for Chronic Low Back Pain in Women With Pelvic Floor Dysfunction

The goal of this clinical trial is to learn whether capacitive-resistive radiofrequency, a supervised core and pelvic floor exercise programme, or both together reduce low back pain in premenopausal women with chronic non-specific low back pain and pelvic floor dysfunction. The main question it aims to answer is: do the three treatments differ in lumbar pain intensity (0-10 visual analogue scale) 1 week after the treatment ends? Researchers will also compare pain quality, low back disability, pelvic floor symptoms, urinary incontinence, pelvic floor muscle function and lumbar mobility up to 3 months after treatment. Sixty women will be randomly assigned to one of three groups: * Radiofrequency: nine weekly 20-minute sessions applied to the lower back and, through a vaginal electrode, to the pelvic floor. * Exercise: a 12-week programme of supervised group sessions (three 30-minute sessions per week) for the core and pelvic floor muscles. * Combined: both treatments at the same time. Participants will complete questionnaires and a physical examination before treatment and 1 week, 1 month and 3 months after treatment ends.

Gender: FEMALE

Ages: 18 Years - Any

Updated: 2026-10-30

1 state

Chronic Low Back Pain
Urinary Incontinence
Pelvic Floor Disorders
RECRUITING

NCT07501065

Prophylactic Antibiotics for Outpatient Urethral Bulking

The purpose of this study is to evaluate whether taking prophylactic (preventative) antibiotics at the time of standard of care clinic-based urethral bulking reduces the risk of post-procedural urinary tract infection (UTI).

Gender: FEMALE

Ages: 18 Years - Any

Updated: 2026-10-29

1 state

Urinary Tract Infections
Stress Urinary Incontinence
Urinary Incontinence
COMPLETED

NCT07900906

Perineal Ultrasound After Bulkamid® Injection for Urinary Incontinence

There are currently different treatment options in the management of stress urinary incontinence (SUI). Given a risk of complications inherent to prosthetic reinforcement and numerous current controversies over the use of a synthetic material, other alternatives must be offered to patients. Peri-urethral injections of filler are increasingly becoming part of the therapeutic arsenal. This is a minimally invasive technique carried out under local anesthesia on an outpatient basis. Peri-urethral injections are currently offered to all patients with stress urinary incontinence, due to sphincter or mixed insufficiency and particularly after suburethral sling failure. Perineal ultrasound after injection allows you to visualize the positioning of the filler bubbles under the bladder neck. In the event of clinical ineffectiveness associated with poor position of the bubbles, this could be an argument for a 2nd injection. If, on the contrary, the bubbles are well positioned, another technique could be proposed.

Gender: FEMALE

Ages: 18 Years - Any

Updated: 2026-10-28

Bulkamid® for Urinary Incontinence
Urinary Incontinence
Ultrasound
COMPLETED

NCT07900880

Quantity of Bulkamid® After Injection for Urinary Incontinence

Bulkamid filler is a gel that we use very regularly to treat female urinary leakage during exercise. It is a minimally invasive technique which is increasingly used around the world because it has almost no adverse effects compared to suburethral slings. The product is injected pre-urethrally and under local anesthesia. The results in terms of improvement are around 70% without knowing why certain patients are improved, slightly improved or not improved at all. One of the hypotheses is that a proportion of the product could be eliminated, and thus the mechanical effect would be reduced. Perineal ultrasound performed in routine practice allows the quantity of gel to be measured in 3 dimensions immediately post-operatively and at 3 months. The objective of this study is to compare the volume of gel between the immediate post-operative and 3 months and to correlate it with clinical results of improvement.

Gender: FEMALE

Ages: 18 Years - Any

Updated: 2026-10-28

Bulkamid® for Urinary Incontinence
Urinary Incontinence
Ultrasound
COMPLETED

NCT06597994

Augmenting Urinary Reflex Activity: Study 3

AURA-3 study (Augmenting Urinary Reflex Activity Study 3) is a single arm, short-duration (8 month) cohort follow up study of preceding interventional medical device study, AURA-2.

Gender: FEMALE

Ages: 18 Years - 75 Years

Updated: 2026-10-27

1 state

Urinary Incontinence
TERMINATED

NCT07028996

Tolerance, Use and Performance of the PEASY Urine Collection Device in Hospitalized Patients

At present, 3 types of urine collection device can be distinguished: absorbent devices (diaper-type), penile clamps and penile collection sheaths. Both pads and penile sheaths are used depending on the department concerned, the clinical context and user preferences. A 2023 survey at Nîmes University Hospital showed that penis sleeves have undesirable side effects like fixation problems and pain on removal, and care assistants reported penile irritation caused by the penis sleeve. Caregivers also reported difficulties when handling and using penis sleeves. There is clearly a need for a better device.To overcome the disadvantages of penis covers, the PEASY project team at Nîmes University Hospital has developed a practical, non-invasive medical device for eliminating urine, positioned on the glans: the PEASY device. This device is held in place by a non-adhesive fastening system that involves the foreskin, to ensure leakage-free urine flow.

Gender: MALE

Ages: 18 Years - Any

Updated: 2026-10-23

Urinary Incontinence
Medical Device Discomfort
RECRUITING

NCT07792031

Comparing the Effect of Two Types of Pelvic Floor Muscle Stimulation Devices to Improve Symptoms of Urinary Incontinence in Women.

This randomized, parallel-group, non-inferiority clinical trial will compare electromagnetic chair therapy with standard electrostimulation combined with biofeedback in 58 adult women with mixed urinary incontinence. Participants will be randomized 1:1 to receive 12 treatment sessions over six weeks. Clinical outcomes will be assessed at baseline, at the end of treatment (week 6), and at week 30. The primary endpoint is the change from baseline to week 6 in the average daily number of total urinary incontinence episodes, recorded in a three-day bladder diary. Secondary outcomes include changes in urgency and stress urinary incontinence episodes, voiding frequency, nocturia, pad use, ICIQ-UI SF scores, patient-reported improvement, responder rates, and urodynamic parameters. Safety and treatment adherence will also be evaluated throughout the study.

Gender: FEMALE

Ages: 18 Years - Any

Updated: 2026-10-23

Urinary Incontinence
Mixed Urinary Incontinence
Urinary Incontinence (UI)
+2
COMPLETED

NCT07413705

BTL-699-2 and HPM-6000UF Devices for the Improvement of Depressive Symptoms and Sexual Function Among Perimenopausal and Postmenopausal Women

The goal of this clinical trial is to evaluate if the combined treatment with EXOMIND (BTL-699-2) and EMSELLA (HPM-6000UF) devices is able to improve depressive symptoms and sexual function in women who are perimenopausal or postmenopausal without an alternative medical cause before enrollment in the study and are aged 40 years and older. The main question it aims to answer is: Does the combined treatment with EXOMIND (BTL-699-2) and EMSELLA (HPM-6000UF) devices improve depressive symptoms and urinary incontinence? Participants will be asked to: Undergo twelve treatments Complete the Patient Health Questionnaire-9 Complete the 6-item Hamilton Depression Rating Scale Complete the Greene Climacteric Scale Complete the Therapy Comfort Questionnaire Complete the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short Form Complete the Female Sexual Function Index Complete the Warwick-Edinburgh Mental Wellbeing Scale Complete the Columbia Suicide Severity Rating Scale-Screen version Complete the Subject Satisfaction Questionnaire Complete the Therapy Comfort Questionnaire

Gender: FEMALE

Ages: 40 Years - Any

Updated: 2026-10-22

3 states

Depressive Symptoms
Urinary Incontinence
Sexual Dysfunction
COMPLETED

NCT06850259

This Study Will Collect Clinical and Patient Reported Satisfaction Data From Males Requiring Urine Output Management Overnight in the Home Setting.

This post-market study will assess the performance of and user satisfaction with the PureWick® Male External Catheter in a home setting. The study will also observe safety of the study device and collect information from participants about their experience using the device.

Gender: MALE

Ages: 65 Years - Any

Updated: 2026-10-21

2 states

Urinary Incontinence
RECRUITING

NCT07276295

Synthetic Versus Autologous Sling For Stress Incontinence

This is a multi-centre randomized controlled trial comparing mid-urethral synthetic mesh sling or tension-free vaginal tape (TVT) and autologous fascia sling (AFS) in elderly patients with stress predominant urinary incontinence. The investigators aim to investigate new onset pelvic pain 6 months post-op and objective urinary incontinence cure rate 5 years post-op. Secondary objectives include investigation of opioid use, mental health, sexual health, and other post-op outcomes.

Gender: FEMALE

Ages: 18 Years - Any

Updated: 2026-10-14

3 states

Urinary Incontinence
RECRUITING

NCT07219433

Implementing a Mobile Health Application for Women Veterans With Urinary Incontinence (MyHealtheBladder): Function QUERI 3.0

Implementing a Mobile Health Application for Women Veterans with Urinary Incontinence (MyHealtheBladder): Function QUERI 3.0 aims to compare implementation approaches while also gathering information on clinical effects of the Evidence-Based Program (EBP) in its new context and focusing on equitable reach (extent to which the program serves all members of its intended audience). The overall goal is to implement, evaluate, and sustain MyHealtheBladder in 20 VA facilities using a type III effectiveness-implementation hybrid study framework and parallel cluster randomized trial (CRT) design.

Gender: FEMALE

Updated: 2026-10-09

1 state

Urinary Incontinence
RECRUITING

NCT07104292

Pelvic Floor Muscle Training During Pregnancy

The project seeks to investigate effectiveness of PFMT during pregnancy.

Gender: FEMALE

Ages: 18 Years - Any

Updated: 2026-10-08

1 state

Urinary Incontinence
Anal Incontinence
Pelvic Organ Prolapse
+2